Immunoassay for determining the release of neurotensin into the circulation
AssigneeSphingotec GmbH
InventorAndrea ERNST
Life of this patent
Estimating the term…
Abstract
The invention relates to an immunodiagnostic determination method for determining the release of neurotensin into the circulation of mammals during which an immunoreactivity of the N-terminal portion of a mammal proneurotensin (PNT immunoreactivity) is selectively determined in a serum sample or plasma sample of a test mammal, this immunoreactivity not being a neurotensin or neuromedin immunoreactivity.
Claims31
1-18. (canceled)
An immunodiagnostic assay method for determining the release of neurotensin (amino acids 151-163 of SEQ ID NO:1) into the circulation of a mammal, comprising
- a. contacting a plasma or serum sample obtained from said mammal with at least one antibody which specifically binds to an immunoreactive portion of a polypeptide having the amino acid sequence of amino acids 24-140 of SEQ ID NO:1, and
- b. determining the amount of bound antibody.
A kit for determining the release of neurotensin (amino acids 151-163 of SEQ ID NO:1) from a precursor of neurotensin into the circulation of a mammal, said kit comprising
- a. a first antibody that specifically binds to a first region within amino acids 24-140 of SEQ ID NO:1;
- and
- b. a second antibody that specifically binds to one or more amino acids of a second region within amino acids 24 to 140 of SEQ ID NO:1,
- wherein both of said first and second antibodies selectively bind to a polypeptide comprising amino acids 24 to 140 of SEQ ID NO:1, but do not bind to neurotensin or neuromedin, and wherein at least one of said first and second antibodies is labeled with a detectable marker.
An immunodiagnostic assay method, comprising
- a. contacting a plasma or serum sample obtained from a mammal with at least one antibody which specifically binds to an immunoreactive portion of a polypeptide having the amino acid sequence of amino acids 24-140 of SEQ ID NO:1, and
- b. determining the amount of bound antibody;
- whereby the amount of said polypeptide is determined.
Dependencies are inferred from the claim text.